Global Lisinopril Market Insights, Forecast to 2029

Publisher Name :
Date: 17-Jul-2023
No. of pages: 129
Inquire Before Buying

Lisinopril is typically used for the treatment of high blood pressure, congestive heart failure, acute myocardial infarction (heart attack), and diabetic nephropathy

The global Lisinopril market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lisinopril is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Lisinopril is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Lisinopril is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key manufacturers of Lisinopril include Actavis Elizabeth, Apotex, Aurobindo Pharma, Ivax Pharmaceuticals, Lek Pharmaceuticals, Lupin, Mylan Pharmaceuticals, Ranbaxy Pharmaceuticals and Novartis, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes:

This report presents an overview of global market for Lisinopril, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Lisinopril, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Lisinopril, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lisinopril sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Lisinopril market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Lisinopril sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Actavis Elizabeth, Apotex, Aurobindo Pharma, Ivax Pharmaceuticals, Lek Pharmaceuticals, Lupin, Mylan Pharmaceuticals, Ranbaxy Pharmaceuticals and Novartis, etc.

By Company

- Actavis Elizabeth

- Apotex

- Aurobindo Pharma

- Ivax Pharmaceuticals

- Lek Pharmaceuticals

- Lupin

- Mylan Pharmaceuticals

- Ranbaxy Pharmaceuticals

- Novartis

- Teva Pharmaceuticals

- Vintage Pharmaceuticals

- Watson Laboratories

- West Ward Pharmaceutical

- Wockhardt

- Merck Research Laboratories

- Astrazeneca

- Alvogen

- Hikma

- Prinston

- Accord Hlthcare

- CASI Pharms

- Invagen Pharms

- SUN Pharm

Segment by Type

- 2.5mg

- 5mg

- 10mg

- 20mg

- 30mg

- 40mg

Segment by Application

- Hospital

- Drug Store

Segment by Region

- US & Canada

- - U.S.

- - Canada

- China

- Asia (excluding China)

- - Japan

- - South Korea

- - China Taiwan

- Southeast Asia

- - India

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Middle East, Africa, Latin America

- - Brazil

- - Mexico

- - Turkey

- - Israel

- - GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Lisinopril in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Lisinopril manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.

Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 8: China by type, by application sales and revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lisinopril sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Global Lisinopril Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Lisinopril Product Introduction
1.2 Market by Type
1.2.1 Global Lisinopril Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 2.5mg
1.2.3 5mg
1.2.4 10mg
1.2.5 20mg
1.2.6 30mg
1.2.7 40mg
1.3 Market by Application
1.3.1 Global Lisinopril Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drug Store
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Lisinopril Sales Estimates and Forecasts 2018-2029
2.2 Global Lisinopril Revenue by Region
2.2.1 Global Lisinopril Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Lisinopril Revenue by Region (2018-2023)
2.2.3 Global Lisinopril Revenue by Region (2024-2029)
2.2.4 Global Lisinopril Revenue Market Share by Region (2018-2029)
2.3 Global Lisinopril Sales Estimates and Forecasts 2018-2029
2.4 Global Lisinopril Sales by Region
2.4.1 Global Lisinopril Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Lisinopril Sales by Region (2018-2023)
2.4.3 Global Lisinopril Sales by Region (2024-2029)
2.4.4 Global Lisinopril Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Lisinopril Sales by Manufacturers
3.1.1 Global Lisinopril Sales by Manufacturers (2018-2023)
3.1.2 Global Lisinopril Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lisinopril in 2022
3.2 Global Lisinopril Revenue by Manufacturers
3.2.1 Global Lisinopril Revenue by Manufacturers (2018-2023)
3.2.2 Global Lisinopril Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Lisinopril Revenue in 2022
3.3 Global Key Players of Lisinopril, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Lisinopril Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Lisinopril Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Lisinopril, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Lisinopril, Product Offered and Application
3.8 Global Key Manufacturers of Lisinopril, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Lisinopril Sales by Type
4.1.1 Global Lisinopril Historical Sales by Type (2018-2023)
4.1.2 Global Lisinopril Forecasted Sales by Type (2024-2029)
4.1.3 Global Lisinopril Sales Market Share by Type (2018-2029)
4.2 Global Lisinopril Revenue by Type
4.2.1 Global Lisinopril Historical Revenue by Type (2018-2023)
4.2.2 Global Lisinopril Forecasted Revenue by Type (2024-2029)
4.2.3 Global Lisinopril Revenue Market Share by Type (2018-2029)
4.3 Global Lisinopril Price by Type
4.3.1 Global Lisinopril Price by Type (2018-2023)
4.3.2 Global Lisinopril Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Lisinopril Sales by Application
5.1.1 Global Lisinopril Historical Sales by Application (2018-2023)
5.1.2 Global Lisinopril Forecasted Sales by Application (2024-2029)
5.1.3 Global Lisinopril Sales Market Share by Application (2018-2029)
5.2 Global Lisinopril Revenue by Application
5.2.1 Global Lisinopril Historical Revenue by Application (2018-2023)
5.2.2 Global Lisinopril Forecasted Revenue by Application (2024-2029)
5.2.3 Global Lisinopril Revenue Market Share by Application (2018-2029)
5.3 Global Lisinopril Price by Application
5.3.1 Global Lisinopril Price by Application (2018-2023)
5.3.2 Global Lisinopril Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Lisinopril Market Size by Type
6.1.1 US & Canada Lisinopril Sales by Type (2018-2029)
6.1.2 US & Canada Lisinopril Revenue by Type (2018-2029)
6.2 US & Canada Lisinopril Market Size by Application
6.2.1 US & Canada Lisinopril Sales by Application (2018-2029)
6.2.2 US & Canada Lisinopril Revenue by Application (2018-2029)
6.3 US & Canada Lisinopril Market Size by Country
6.3.1 US & Canada Lisinopril Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Lisinopril Sales by Country (2018-2029)
6.3.3 US & Canada Lisinopril Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Lisinopril Market Size by Type
7.1.1 Europe Lisinopril Sales by Type (2018-2029)
7.1.2 Europe Lisinopril Revenue by Type (2018-2029)
7.2 Europe Lisinopril Market Size by Application
7.2.1 Europe Lisinopril Sales by Application (2018-2029)
7.2.2 Europe Lisinopril Revenue by Application (2018-2029)
7.3 Europe Lisinopril Market Size by Country
7.3.1 Europe Lisinopril Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Lisinopril Sales by Country (2018-2029)
7.3.3 Europe Lisinopril Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Lisinopril Market Size
8.1.1 China Lisinopril Sales (2018-2029)
8.1.2 China Lisinopril Revenue (2018-2029)
8.2 China Lisinopril Market Size by Application
8.2.1 China Lisinopril Sales by Application (2018-2029)
8.2.2 China Lisinopril Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Lisinopril Market Size by Type
9.1.1 Asia Lisinopril Sales by Type (2018-2029)
9.1.2 Asia Lisinopril Revenue by Type (2018-2029)
9.2 Asia Lisinopril Market Size by Application
9.2.1 Asia Lisinopril Sales by Application (2018-2029)
9.2.2 Asia Lisinopril Revenue by Application (2018-2029)
9.3 Asia Lisinopril Sales by Region
9.3.1 Asia Lisinopril Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Lisinopril Revenue by Region (2018-2029)
9.3.3 Asia Lisinopril Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Lisinopril Market Size by Type
10.1.1 Middle East, Africa and Latin America Lisinopril Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Lisinopril Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Lisinopril Market Size by Application
10.2.1 Middle East, Africa and Latin America Lisinopril Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Lisinopril Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Lisinopril Sales by Country
10.3.1 Middle East, Africa and Latin America Lisinopril Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Lisinopril Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Lisinopril Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Actavis Elizabeth
11.1.1 Actavis Elizabeth Company Information
11.1.2 Actavis Elizabeth Overview
11.1.3 Actavis Elizabeth Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Actavis Elizabeth Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Actavis Elizabeth Recent Developments
11.2 Apotex
11.2.1 Apotex Company Information
11.2.2 Apotex Overview
11.2.3 Apotex Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Apotex Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Apotex Recent Developments
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Information
11.3.2 Aurobindo Pharma Overview
11.3.3 Aurobindo Pharma Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Aurobindo Pharma Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Aurobindo Pharma Recent Developments
11.4 Ivax Pharmaceuticals
11.4.1 Ivax Pharmaceuticals Company Information
11.4.2 Ivax Pharmaceuticals Overview
11.4.3 Ivax Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Ivax Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ivax Pharmaceuticals Recent Developments
11.5 Lek Pharmaceuticals
11.5.1 Lek Pharmaceuticals Company Information
11.5.2 Lek Pharmaceuticals Overview
11.5.3 Lek Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Lek Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lek Pharmaceuticals Recent Developments
11.6 Lupin
11.6.1 Lupin Company Information
11.6.2 Lupin Overview
11.6.3 Lupin Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Lupin Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lupin Recent Developments
11.7 Mylan Pharmaceuticals
11.7.1 Mylan Pharmaceuticals Company Information
11.7.2 Mylan Pharmaceuticals Overview
11.7.3 Mylan Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Mylan Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mylan Pharmaceuticals Recent Developments
11.8 Ranbaxy Pharmaceuticals
11.8.1 Ranbaxy Pharmaceuticals Company Information
11.8.2 Ranbaxy Pharmaceuticals Overview
11.8.3 Ranbaxy Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Ranbaxy Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ranbaxy Pharmaceuticals Recent Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Overview
11.9.3 Novartis Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Novartis Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novartis Recent Developments
11.10 Teva Pharmaceuticals
11.10.1 Teva Pharmaceuticals Company Information
11.10.2 Teva Pharmaceuticals Overview
11.10.3 Teva Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Teva Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Pharmaceuticals Recent Developments
11.11 Vintage Pharmaceuticals
11.11.1 Vintage Pharmaceuticals Company Information
11.11.2 Vintage Pharmaceuticals Overview
11.11.3 Vintage Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Vintage Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Vintage Pharmaceuticals Recent Developments
11.12 Watson Laboratories
11.12.1 Watson Laboratories Company Information
11.12.2 Watson Laboratories Overview
11.12.3 Watson Laboratories Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Watson Laboratories Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Watson Laboratories Recent Developments
11.13 West Ward Pharmaceutical
11.13.1 West Ward Pharmaceutical Company Information
11.13.2 West Ward Pharmaceutical Overview
11.13.3 West Ward Pharmaceutical Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 West Ward Pharmaceutical Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 West Ward Pharmaceutical Recent Developments
11.14 Wockhardt
11.14.1 Wockhardt Company Information
11.14.2 Wockhardt Overview
11.14.3 Wockhardt Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Wockhardt Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Wockhardt Recent Developments
11.15 Merck Research Laboratories
11.15.1 Merck Research Laboratories Company Information
11.15.2 Merck Research Laboratories Overview
11.15.3 Merck Research Laboratories Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Merck Research Laboratories Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Merck Research Laboratories Recent Developments
11.16 Astrazeneca
11.16.1 Astrazeneca Company Information
11.16.2 Astrazeneca Overview
11.16.3 Astrazeneca Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Astrazeneca Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Astrazeneca Recent Developments
11.17 Alvogen
11.17.1 Alvogen Company Information
11.17.2 Alvogen Overview
11.17.3 Alvogen Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Alvogen Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Alvogen Recent Developments
11.18 Hikma
11.18.1 Hikma Company Information
11.18.2 Hikma Overview
11.18.3 Hikma Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 Hikma Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Hikma Recent Developments
11.19 Prinston
11.19.1 Prinston Company Information
11.19.2 Prinston Overview
11.19.3 Prinston Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.19.4 Prinston Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Prinston Recent Developments
11.20 Accord Hlthcare
11.20.1 Accord Hlthcare Company Information
11.20.2 Accord Hlthcare Overview
11.20.3 Accord Hlthcare Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.20.4 Accord Hlthcare Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Accord Hlthcare Recent Developments
11.21 CASI Pharms
11.21.1 CASI Pharms Company Information
11.21.2 CASI Pharms Overview
11.21.3 CASI Pharms Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.21.4 CASI Pharms Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 CASI Pharms Recent Developments
11.22 Invagen Pharms
11.22.1 Invagen Pharms Company Information
11.22.2 Invagen Pharms Overview
11.22.3 Invagen Pharms Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.22.4 Invagen Pharms Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Invagen Pharms Recent Developments
11.23 SUN Pharm
11.23.1 SUN Pharm Company Information
11.23.2 SUN Pharm Overview
11.23.3 SUN Pharm Lisinopril Sales, Price, Revenue and Gross Margin (2018-2023)
11.23.4 SUN Pharm Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 SUN Pharm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lisinopril Industry Chain Analysis
12.2 Lisinopril Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lisinopril Production Mode & Process
12.4 Lisinopril Sales and Marketing
12.4.1 Lisinopril Sales Channels
12.4.2 Lisinopril Distributors
12.5 Lisinopril Customers
13 Market Dynamics
13.1 Lisinopril Industry Trends
13.2 Lisinopril Market Drivers
13.3 Lisinopril Market Challenges
13.4 Lisinopril Market Restraints
14 Key Findings in The Global Lisinopril Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Lisinopril Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 2.5mg
Table 3. Major Manufacturers of 5mg
Table 4. Major Manufacturers of 10mg
Table 5. Major Manufacturers of 20mg
Table 6. Major Manufacturers of 30mg
Table 7. Major Manufacturers of 40mg
Table 8. Global Lisinopril Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Lisinopril Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Lisinopril Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global Lisinopril Revenue by Region (2024-2029) & (US$ Million)
Table 12. Global Lisinopril Revenue Market Share by Region (2018-2023)
Table 13. Global Lisinopril Revenue Market Share by Region (2024-2029)
Table 14. Global Lisinopril Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 15. Global Lisinopril Sales by Region (2018-2023) & (K Units)
Table 16. Global Lisinopril Sales by Region (2024-2029) & (K Units)
Table 17. Global Lisinopril Sales Market Share by Region (2018-2023)
Table 18. Global Lisinopril Sales Market Share by Region (2024-2029)
Table 19. Global Lisinopril Sales by Manufacturers (2018-2023) & (K Units)
Table 20. Global Lisinopril Sales Share by Manufacturers (2018-2023)
Table 21. Global Lisinopril Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 22. Global Lisinopril Revenue Share by Manufacturers (2018-2023)
Table 23. Global Key Players of Lisinopril, Industry Ranking, 2021 VS 2022 VS 2023
Table 24. Lisinopril Price by Manufacturers 2018-2023 (US$/Unit)
Table 25. Global Lisinopril Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Lisinopril by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lisinopril as of 2022)
Table 27. Global Key Manufacturers of Lisinopril, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Lisinopril, Product Offered and Application
Table 29. Global Key Manufacturers of Lisinopril, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Lisinopril Sales by Type (2018-2023) & (K Units)
Table 32. Global Lisinopril Sales by Type (2024-2029) & (K Units)
Table 33. Global Lisinopril Sales Share by Type (2018-2023)
Table 34. Global Lisinopril Sales Share by Type (2024-2029)
Table 35. Global Lisinopril Revenue by Type (2018-2023) & (US$ Million)
Table 36. Global Lisinopril Revenue by Type (2024-2029) & (US$ Million)
Table 37. Global Lisinopril Revenue Share by Type (2018-2023)
Table 38. Global Lisinopril Revenue Share by Type (2024-2029)
Table 39. Lisinopril Price by Type (2018-2023) & (US$/Unit)
Table 40. Global Lisinopril Price Forecast by Type (2024-2029) & (US$/Unit)
Table 41. Global Lisinopril Sales by Application (2018-2023) & (K Units)
Table 42. Global Lisinopril Sales by Application (2024-2029) & (K Units)
Table 43. Global Lisinopril Sales Share by Application (2018-2023)
Table 44. Global Lisinopril Sales Share by Application (2024-2029)
Table 45. Global Lisinopril Revenue by Application (2018-2023) & (US$ Million)
Table 46. Global Lisinopril Revenue by Application (2024-2029) & (US$ Million)
Table 47. Global Lisinopril Revenue Share by Application (2018-2023)
Table 48. Global Lisinopril Revenue Share by Application (2024-2029)
Table 49. Lisinopril Price by Application (2018-2023) & (US$/Unit)
Table 50. Global Lisinopril Price Forecast by Application (2024-2029) & (US$/Unit)
Table 51. US & Canada Lisinopril Sales by Type (2018-2023) & (K Units)
Table 52. US & Canada Lisinopril Sales by Type (2024-2029) & (K Units)
Table 53. US & Canada Lisinopril Revenue by Type (2018-2023) & (US$ Million)
Table 54. US & Canada Lisinopril Revenue by Type (2024-2029) & (US$ Million)
Table 55. US & Canada Lisinopril Sales by Application (2018-2023) & (K Units)
Table 56. US & Canada Lisinopril Sales by Application (2024-2029) & (K Units)
Table 57. US & Canada Lisinopril Revenue by Application (2018-2023) & (US$ Million)
Table 58. US & Canada Lisinopril Revenue by Application (2024-2029) & (US$ Million)
Table 59. US & Canada Lisinopril Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 60. US & Canada Lisinopril Revenue by Country (2018-2023) & (US$ Million)
Table 61. US & Canada Lisinopril Revenue by Country (2024-2029) & (US$ Million)
Table 62. US & Canada Lisinopril Sales by Country (2018-2023) & (K Units)
Table 63. US & Canada Lisinopril Sales by Country (2024-2029) & (K Units)
Table 64. Europe Lisinopril Sales by Type (2018-2023) & (K Units)
Table 65. Europe Lisinopril Sales by Type (2024-2029) & (K Units)
Table 66. Europe Lisinopril Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Lisinopril Revenue by Type (2024-2029) & (US$ Million)
Table 68. Europe Lisinopril Sales by Application (2018-2023) & (K Units)
Table 69. Europe Lisinopril Sales by Application (2024-2029) & (K Units)
Table 70. Europe Lisinopril Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Lisinopril Revenue by Application (2024-2029) & (US$ Million)
Table 72. Europe Lisinopril Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 73. Europe Lisinopril Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Lisinopril Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Lisinopril Sales by Country (2018-2023) & (K Units)
Table 76. Europe Lisinopril Sales by Country (2024-2029) & (K Units)
Table 77. China Lisinopril Sales by Type (2018-2023) & (K Units)
Table 78. China Lisinopril Sales by Type (2024-2029) & (K Units)
Table 79. China Lisinopril Revenue by Type (2018-2023) & (US$ Million)
Table 80. China Lisinopril Revenue by Type (2024-2029) & (US$ Million)
Table 81. China Lisinopril Sales by Application (2018-2023) & (K Units)
Table 82. China Lisinopril Sales by Application (2024-2029) & (K Units)
Table 83. China Lisinopril Revenue by Application (2018-2023) & (US$ Million)
Table 84. China Lisinopril Revenue by Application (2024-2029) & (US$ Million)
Table 85. Asia Lisinopril Sales by Type (2018-2023) & (K Units)
Table 86. Asia Lisinopril Sales by Type (2024-2029) & (K Units)
Table 87. Asia Lisinopril Revenue by Type (2018-2023) & (US$ Million)
Table 88. Asia Lisinopril Revenue by Type (2024-2029) & (US$ Million)
Table 89. Asia Lisinopril Sales by Application (2018-2023) & (K Units)
Table 90. Asia Lisinopril Sales by Application (2024-2029) & (K Units)
Table 91. Asia Lisinopril Revenue by Application (2018-2023) & (US$ Million)
Table 92. Asia Lisinopril Revenue by Application (2024-2029) & (US$ Million)
Table 93. Asia Lisinopril Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 94. Asia Lisinopril Revenue by Region (2018-2023) & (US$ Million)
Table 95. Asia Lisinopril Revenue by Region (2024-2029) & (US$ Million)
Table 96. Asia Lisinopril Sales by Region (2018-2023) & (K Units)
Table 97. Asia Lisinopril Sales by Region (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Lisinopril Sales by Type (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Lisinopril Sales by Type (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Lisinopril Revenue by Type (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Lisinopril Revenue by Type (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Lisinopril Sales by Application (2018-2023) & (K Units)
Table 103. Middle East, Africa and Latin America Lisinopril Sales by Application (2024-2029) & (K Units)
Table 104. Middle East, Africa and Latin America Lisinopril Revenue by Application (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Lisinopril Revenue by Application (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Lisinopril Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 107. Middle East, Africa and Latin America Lisinopril Revenue by Country (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Lisinopril Revenue by Country (2024-2029) & (US$ Million)
Table 109. Middle East, Africa and Latin America Lisinopril Sales by Country (2018-2023) & (K Units)
Table 110. Middle East, Africa and Latin America Lisinopril Sales by Country (2024-2029) & (K Units)
Table 111. Actavis Elizabeth Company Information
Table 112. Actavis Elizabeth Description and Major Businesses
Table 113. Actavis Elizabeth Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Actavis Elizabeth Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Actavis Elizabeth Recent Developments
Table 116. Apotex Company Information
Table 117. Apotex Description and Major Businesses
Table 118. Apotex Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Apotex Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Apotex Recent Developments
Table 121. Aurobindo Pharma Company Information
Table 122. Aurobindo Pharma Description and Major Businesses
Table 123. Aurobindo Pharma Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Aurobindo Pharma Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Aurobindo Pharma Recent Developments
Table 126. Ivax Pharmaceuticals Company Information
Table 127. Ivax Pharmaceuticals Description and Major Businesses
Table 128. Ivax Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Ivax Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Ivax Pharmaceuticals Recent Developments
Table 131. Lek Pharmaceuticals Company Information
Table 132. Lek Pharmaceuticals Description and Major Businesses
Table 133. Lek Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Lek Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Lek Pharmaceuticals Recent Developments
Table 136. Lupin Company Information
Table 137. Lupin Description and Major Businesses
Table 138. Lupin Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. Lupin Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Lupin Recent Developments
Table 141. Mylan Pharmaceuticals Company Information
Table 142. Mylan Pharmaceuticals Description and Major Businesses
Table 143. Mylan Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. Mylan Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Mylan Pharmaceuticals Recent Developments
Table 146. Ranbaxy Pharmaceuticals Company Information
Table 147. Ranbaxy Pharmaceuticals Description and Major Businesses
Table 148. Ranbaxy Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 149. Ranbaxy Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Ranbaxy Pharmaceuticals Recent Developments
Table 151. Novartis Company Information
Table 152. Novartis Description and Major Businesses
Table 153. Novartis Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 154. Novartis Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Novartis Recent Developments
Table 156. Teva Pharmaceuticals Company Information
Table 157. Teva Pharmaceuticals Description and Major Businesses
Table 158. Teva Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 159. Teva Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Teva Pharmaceuticals Recent Developments
Table 161. Vintage Pharmaceuticals Company Information
Table 162. Vintage Pharmaceuticals Description and Major Businesses
Table 163. Vintage Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 164. Vintage Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Vintage Pharmaceuticals Recent Developments
Table 166. Watson Laboratories Company Information
Table 167. Watson Laboratories Description and Major Businesses
Table 168. Watson Laboratories Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 169. Watson Laboratories Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Watson Laboratories Recent Developments
Table 171. West Ward Pharmaceutical Company Information
Table 172. West Ward Pharmaceutical Description and Major Businesses
Table 173. West Ward Pharmaceutical Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 174. West Ward Pharmaceutical Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. West Ward Pharmaceutical Recent Developments
Table 176. Wockhardt Company Information
Table 177. Wockhardt Description and Major Businesses
Table 178. Wockhardt Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 179. Wockhardt Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 180. Wockhardt Recent Developments
Table 181. Merck Research Laboratories Company Information
Table 182. Merck Research Laboratories Description and Major Businesses
Table 183. Merck Research Laboratories Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 184. Merck Research Laboratories Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 185. Merck Research Laboratories Recent Developments
Table 186. Astrazeneca Company Information
Table 187. Astrazeneca Description and Major Businesses
Table 188. Astrazeneca Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 189. Astrazeneca Lisinopril Product Model Numbe
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs